News
Affluent Medical appoints Liane Teplitsky as a new member of the Board of Directors
10th successful human implantation of Artus urinary sphincter, marking completion of the pilot phase
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO
Interview with Dr. Sarraf
Epygon: A unique device for mitral valve repair
Interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, in the “Actu Bourse” issue on Boursorama
12 September 2024
Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
12 july 2024